Renalytix Ai Plc-adr(RNLX)
$0.51
Market is closed - opens 7 PM, 20 May 2024
Insights
- Renalytix Ai Plc-adr is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.
- Based on analysis of the Oscillators technical indicator, the current market trend for Renalytix Ai Plc-adr stock suggests that it is range bound and no decision can be made based on this information
- Based on analysis of the Moving Averages technical indicator, Renalytix Ai Plc-adr stock is in a downtrend↘️
- Based on analysis of the Pivot Points, the current market trend for Renalytix Ai Plc-adr stock suggests that it is a good time to sell or bad time to initiate a fresh position
Analysis Summary
Oscillators
Sell
Neutral
Buy
Moving Averages
Sell
Neutral
Buy
Pivots
Sell
Neutral
Buy
Oscillators
Name | Value | Action |
|---|---|---|
Relative Strength Index | 33.63 | Neutral |
Stochastic | 0.82, 11.96 | Neutral |
Ultimate Oscillator | 35.75 | Neutral |
Stochastic Relative Strength Index | 7.05, 19.48 | Neutral |
Moving Average Convergence Divergence | -0.06, -0.05 | Neutral |
Moving Averages
Simple Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 0.62 | Sell |
20 | 0.66 | Sell |
50 | 0.8 | Buy |
Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 0.61 | Sell |
20 | 0.66 | Sell |
50 | 0.72 | Buy |
Volume Weighted Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 0.61 | Sell |
20 | 0.66 | Sell |
50 | 0.81 | Sell |
Double Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 0.56 | Sell |
20 | 0.58 | Sell |
50 | 0.72 | Sell |
Triple Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 0.55 | Sell |
20 | 0.56 | Sell |
50 | 0.62 | Sell |
Pivot
Pivot | Value |
|---|---|
Resistance L3 | 0.62 |
Resistance L2 | 0.61 |
Resistance L1 | 0.6 |
Pivot Point | 0.59 |
Support L1 | 0.58 |
Support L2 | 0.57 |
Support L3 | 0.56 |
*Disclaimer: The content present here is for informational purposes only, you should not construe any such information or other material as investment advisory.